Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-11-11Clinical Trial Update: Effectiveness of SMS-text Message Support for Patients With Hypertension to Improve Blood Pressure [NA]
A completed clinical trial evaluated the effectiveness of SMS-text message support for patients with hypertension to improve blood pressure.
-
CLINICAL_TRIALS trial_result · 2014-11-11Clinical Trial Update: Monitoring Hypertensive Patients's Cerebral Oxygen Saturation
Clinical trial update on monitoring cerebral oxygen saturation in hypertensive patients during general anesthesia; the study status is compl…
-
FDA approval · 2014-11-10FDA Approved: GUANFACINE — Supplemental Application (Actavis Pharma, Inc.)
The FDA approved Actavis Pharma, Inc.'s supplemental application for guanfacine, enabling the generic product to enter the market.
-
CLINICAL_TRIALS trial_result · 2014-11-10Clinical Trial Update: Renal Denervation in Patients With Refractory Hypertension [NA]
This update notes the completion of a Medtronic Vascular-sponsored clinical trial evaluating renal denervation for patients with refractory …
-
CLINICAL_TRIALS research · 2014-11-07Clinical Trial Update: Study of the Relationships Between Refractory Hypertension, Overweight/Obesity and Sleep Apnea Syndrome [Phase 3]
Phase 3 clinical study examining relationships between refractory hypertension, overweight/obesity, and sleep apnea; the trial status is com…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2014-11-07FDA Approved: ATENOLOL — Supplemental Application (Ipca Laboratories Limited)
FDA approved a supplemental application for Atenolol from Ipca Laboratories Limited under an ANDA.
-
CLINICAL_TRIALS research · 2014-11-06Clinical Trial Update: Predictors of Blood Pressure Control and Associations With Cardiovascular Diseases in Individuals With High Blood Pressure: a CALIBER Study
The CALIBER study update investigates predictors of achieving blood pressure control and how hypertension relates to cardiovascular disease …
-
FDA approval · 2014-11-05FDA Approved: AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
The FDA approved Lupin Pharmaceuticals' supplemental application for a fixed-dose combination of amlodipine besylate and benazepril hydrochl…
-
CLINICAL_TRIALS trial_result · 2014-11-05Clinical Trial Update: Safety Study to Lower the Risk of Heart Failure is Also Effective in Reducing Stiffness of the Arteries [Phase 2, Phase 3]
Phase 2/3 safety study evaluated a treatment intended to lower the risk of heart failure and reduce arterial stiffness in patients with hype…
-
FDA approval · 2014-11-05FDA Approved: LOSARTAN POTASSIUM — Supplemental Application (Micro Labs Limited)
FDA approves a supplemental application for losartan potassium from Micro Labs Limited.
-
CLINICAL_TRIALS trial_result · 2014-11-05Clinical Trial Update: Impact of Yoga on Blood Pressure, Quality of Life and Stress in Patients With Hypertension [NA]
This update reports on a completed clinical trial evaluating whether yoga can improve blood pressure, quality of life, and stress in people …
-
FDA approval · 2014-11-04FDA Approved: LOSARTAN POTASSIUM — Supplemental Application (Macleods Pharmaceuticals Limited)
The FDA has granted supplemental approval for Losartan Potassium from Macleods Pharmaceuticals Limited. This action approves the supplementa…
-
FDA approval · 2014-11-04FDA Approved: LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE — Supplemental Application (Macleods Pharmaceuticals Limited)
FDA approved a supplemental application for Losartan Potassium and Hydrochlorothiazide from Macleods Pharmaceuticals Limited. The product is…
-
FDA approval · 2014-11-04FDA Approved: ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE — Supplemental Application (Taro Pharmaceuticals U.S.A., Inc.)
The FDA approved a supplemental application for ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE from Taro Pharmaceuticals U.S.A., Inc., adding a g…
-
FDA approval · 2014-11-03FDA Approved: CAPTOPRIL — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved Hikma Pharmaceuticals USA's supplemental application for captopril (CAPTOPRIL), enabling the generic captopril product under th…
-
CLINICAL_TRIALS trial_result · 2014-11-03Clinical Trial Update: Effect of a Treatment of Lifestyle Changes on the Prevalence of Metabolic Syndrome and Body Weight in Mexican Women [NA]
A completed trial assessing whether lifestyle changes reduce the prevalence of metabolic syndrome and affect body weight in Mexican women.
-
CLINICAL_TRIALS trial_result · 2014-11-03Clinical Trial Update: Evaluation of Antihypertensive Drugs in OSA Patients
A completed clinical trial evaluated antihypertensive drugs in patients with hypertension and obstructive sleep apnea.
-
FDA approval · 2014-10-31FDA Approved: AMLODIPINE AND BENAZEPRIL HYDROCHLORIDE — Supplemental Application (Rising Pharma Holdings, Inc.)
The FDA approved a supplemental application for amlodipine and benazepril hydrochloride (Rising Pharma Holdings, Inc.), granting a supplemen…
-
FDA approval · 2014-10-31FDA Approved: LISINOPRIL — Supplemental Application (Solco healthcare U.S., LLC)
The FDA approved a supplemental application for lisinopril from Solco Healthcare U.S., LLC.
-
FDA approval · 2014-10-30FDA Approved: LOPRESSOR — Supplemental Application (Validus Pharmaceuticals LLC)
FDA approved a supplemental application for Lopressor (metoprolol tartrate) from Validus Pharmaceuticals LLC.
-
FDA approval · 2014-10-28FDA Approved: METOPROLOL TARTRATE — Original Application (TRUPHARMA LLC)
FDA approved TRUPHARMA LLC's original ANDA for metoprolol tartrate, enabling a generic version of this beta-blocker. The approval makes meto…
-
CLINICAL_TRIALS trial_result · 2014-10-27Clinical Trial Update: Nutritional Treatment of Overweight Adolescents With Cardiovascular Risk Factors (PowerUp) [NA]
The PowerUp clinical trial evaluating nutritional treatment for overweight adolescents with cardiovascular risk factors was terminated; no r…
-
FDA approval · 2014-10-26FDA Approved: AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE — Supplemental Application (Dr.Reddy's Laboratories Limited)
FDA approved a supplemental application for amlodipine besylate and benazepril hydrochloride from Dr. Reddy's Laboratories Limited (a generi…
-
FDA approval · 2014-10-26FDA Approved: AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE — Supplemental Application (Dr.Reddy's Laboratories Limited)
FDA approved a supplemental application for Dr. Reddy's Laboratories Limited for amlodipine besylate and benazepril hydrochloride, a generic…
-
CLINICAL_TRIALS research · 2014-10-24Clinical Trial Update: PCI and Renal Denervation in Hypertensive Patients With Acute Coronary Syndromes [Phase 2]
Phase 2 clinical trial update evaluating percutaneous coronary intervention and renal denervation in hypertensive patients with acute corona…